Carlo Lanza，医学博士，哲学博士
Carlo Lanza, MD, PhD, is Executive Medical Officer for Fortrea, based in Lugano, Switzerland. Dr. Lanza performs medical monitoring and safety assessments on Phase I-IV clinical trials for Fortrea clients. 他负责领导早期和转化研究早期研发项目，针对靶向疗法、小分子、生物制剂和基因疗法。Lanza博士还负责监督后期研发策略的开发、登记程序的交付和审批。他在临床研发方面拥有超过20年经验，并曾担任医师和医疗主任，专长于儿科和肿瘤学。
Before joining Fortrea, he served as Medical Director for Medicines for Malaria Venture in Geneva, Switzerland. Lanza博士还曾在Novartis Oncology、Pfizer全球研发和AstraZeneca英国分公司担任领导职务。 Carlo joined our company in 2012.
